Signalling pathways mediating secretory and mitogenic responses to galanin and pituitary adenylate cyclase-activating polypeptide in the 235-1 clonal rat lactotroph cell line

Journal of Neuroendocrinology

Volumn 8, Issue 6, 1996, Pages 457-464

  Hammond, P J ^a   Smith, D M ^a   Akinsanya, K O ^a   Mufti, W A ^a   Wynick, D ^a   Bloom, S R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Galanin; Growth factor; Pituitary; Pituitary adenylate cyclase activating polypeptide; Prolactin

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; CYCLIC AMP; GALANIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INOSITOL PHOSPHATE; NEUROPEPTIDE; PHOSPHOLIPASE C; PROLACTIN; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; CELL LINE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0029767698     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1996.04747.x     Document Type: Article

References (51)

1. Vrontakis M, Peden L, Duckworth ML, Friesen HG. Isolation and characterization of a complementary DNA (galanin) clone from estrogen induced pituitary tumor messenger RNA. J Biol Chem 1987; 262: 55-58.
2. Kaplan LM, Gabriel SM, Koenig JI et al., Galanin is an estrogen inducible, secretory product of the rat anterior pituitary. Proc Natl Acad Sci USA 1988; 85: 7408-7412.
3. Hemmer A, Hyde JF. Regulation of galanin secretion from pituitary cells in vitro by estradiol and GHRH. Peptides 1992; 13: 1201-1206.
4. Wynick D, Hammond PJ, Akinsanya KO, Bloom SR. Galanin regulates basal and oestrogen stimulated lactotroph function. Nature 1993; 364: 529-532.
5. Steel JH, Gon G, O'Halloran DJ et al. Galanin and vasoactive intestinal polypeptide are colocalised with classical pituitary hormones and show plasticity of expression. Histochemistry 1989; 93: 183-189.
6. Melander T, Fuxe K, Harfstrand A, Eneroth P, Hokfelt T. Effects of intraventricular injections of galanin on neuroendocrine functions in the male rat. Possible involvement of hypothalamic catecholamine neuronal systems. Acta Physiol Scand 1987; 131: 25-32.
7. Lopez FJ, Meade EHJ, Negro Vilar A. Endogenous galanin modulates the gonadotropin and prolactin proestrous surges in the rat. Endocrinology 1993; 132: 795-800.
8. Bartfai T, Langel U, Bedecs K et al. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc Natl Acad Sci USA 1993; 90: 11287-11291.
9. Fisone G, Langel U, Carlquist M et al. Galanin receptor and its ligands in the rat hippocampus. Eur J Biochem 1989; 181: 269-276.
10. Gillison SL, Sharp GW. ADP ribosylation by cholera toxin identifies three G-proteins that are activated by the galanin receptor. Studies with RINm5F cell membranes. Diabetes 1994; 43: 24-32.
11. de Weille J, Schmid Antomarchi H, Fosset M, Lazdunski M. ATP-sensitive K + channels that are blocked by hypoglycemia-inducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing hormone. Proc Natl Acad Sci USA 1988; 85: 1312-1316.
12. Dunne MJ, Bullett MJ, Li GD, Wollheim CB, Petersen OH. Galanin activates nucleotide-dependent K + channels in insulin-secreting cells via a pertussis toxin-sensitive G-protein. EMBO J 1989; 8: 413-420.
13. Sharp GW, Le Marchand Brustel Y, Yada T et al. Galanin can inhibit insulin release by a mechanism other than membrane hyperpolarization or inhibition of adenylate cyclase. J Biol Chem 1989; 264: 7302-7309.
14. Nilsson T, Arkhammar P, Rorsman P, Berggren PO. Suppression of insulin release by galanin and somatostatin is mediated by a G-protein. An effect involving repolarization and reduction in cytoplasmic free Ca2 + concentration. J Biol Chem 1989; 264: 973-980.
15. Amiranoff B, Lorinet AM, Lagny Pourmir I, Laburthe M. Mechanism of galanin-inhibited insulin release. Occurrence of a pertussis-toxin-sensitive inhibition of adenylate cyclase. Eur J Biochem 1988; 177: 147-152.
16. Chen Y, Laburthe M, Amiranoff B. Galanin inhibits adenylate cyclase of rat brain membranes. Peptides 1992; 13: 339-341.
17. Fehmann HC, Habener JF. Galanin inhibits proinsulin gene expression stimulated by the insulinotropic hormone glucagon-like peptide-I (7-37) in mouse insulinoma beta TC-1 cells. Endocrinology 1992; 130: 2890-2896.
18. Wynick D, Smith DM, Ghatei M et al. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: Absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor. Proc Natl Acad Sci USA 1993; 90: 4231-4235.
19. Sethi T, Rozengurt E. Galanin stimulates Ca2 + mobilization, inositol phosphate accumulation, and clonal growth in small cell lung cancer cells. Cancer Res 1991; 51: 1674-1679.
20. Miyata A, Arimura A, Dahl RR et al. Isolation of a novel 58 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989; 164: 567-574.
21. Ghatei MA, Takahashi K, Suzuki Y, Gardiner J, Jones PM, Bloom SR. Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues. J Endocrinol 1993; 136: 159-166.
22. Gottschall PE, Tatsuno I, Miyata A, Arimura A. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. Endocrinology 1990; 127: 272-277.
23. Shivers BD, Gores TJ, Gottschall PE, Arimura A. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology 1991; 128: 3055-3065.
24. Deutsch PJ, Sun Y. The 38-amino acid form of pituitary adenylate cyclase-activating polypeplide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J Biol Chem 1992; 267: 5108-5113.
25. Schomerus E, Poch A, Bunting R, Mason WT, McArdle CA. Effects of pituitary adenylate cyclase-activating polypeptide in the pituitary: activation of two signal transduction pathways in the gonadotrope-derived aT3-1 cell line. Endocrinology 1994; 134: 315-323.
26. Rawlings SR, Demaurex N, Schlegel W. Pituitary adenylate cyclase-activating polypeptide increases [Ca2 +] i in rat gonadotrophs through an inositol trisphosphate-dependent mechanism. J Biol Chem 1994; 269: 5680-5686.
27. Culler MD, Paschall CS. Pituitary adenylate cyclase-activating polypeptide (PACAP) potentiates the gonadotropin-releasing activity of luteinizing hormone-releasing hormone. Endocrinology 1991; 129: 2260-2262.
28. Hart GR, Gowing H, Burrin JM. Effects of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, on pituitary hormone release in rats. J Endocrinol 1992; 134: 33-41.
29. Vigh S, Arimura A, Gottschall PE, Kitada C, Somogyvari Vigh A, Childs GV. Cytochemical characterization of anterior pituitary target cells for the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP), using biotinylated ligands. Peptides 1993; 14: 59-65.
30. Propato Mussafiri R, Kanse SM, Ghatei MA, Bloom SR. Pituitary adenylate cyclase-activating polypeptide releases 7B2, adrenocorticotrophin, growth hormone and prolactin from the mouse and rat clonal pituitary cell lines AtT-20 and GH3. J Endocrinol 1992; 132: 107-113.
31. Coleman DT, Bancroft C. Pituitary adenylate cyclase-activating polypeptide stimulates prolactin gene expression in a rat pituitary cell line. Endocrinology 1993; 133: 2736-2742.
32. Canny BJ, Rawlings SR, Leong DA. Pituitary adenylate cyclase-activating polypeptide specifically increases cytosolic calcium ion concentration in rat gonadotropes and somatotropes. Endocrinology 1992; 130: 211-215.
33. Gracia Navarro F, Lamacz M, Tonon MC, Vaudry H. Pituitary adenylate cyclase-activating polypeptide stimulates calcium mobilization in amphibian pituitary cells. Endocrinology 1992; 131: 1069-1074.
34. Spengler D, Waeber C, Pantaloni C et al. Signal transduction by five splice variants of the PACAP receptor. Nature 1993; 365: 170-175.
35. Cronin MJ, Perkins SN, Keefer DA, MacLeod RM. Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 clone. Mol Cell Endocrinol 1982; 28: 229-246.
36. Reymond MJ, Nansel DD, Burrows GH, Neaves WB, Porter JC. A new clonal strain of rat pituitary tumour cells: a model for non-regulated secretion of prolactin. Acta Endocrinol Copenh 1984; 106: 459-470.
37. Schettini G, Rogol AD, MacLeod RM, Yasumoto T, Cronin MJ. Agents that increase cellular cyclic AMP or calcium stimulate prolactin release from the 235-1 pituitary cell line. Eur J Pharmacol 1985; 109: 335-340.
38. Lopez FJ, Merchenthaler I, Ching M, Wisniewski MG, Negro Vilar A. Galanin: a hypothalamic-hypophysiotropic hormone modulating reproductive functions. Proc Natl Acad Sci USA 1991; 88: 4508-4512.
39. Jarry H, Leonhardt S, Schmidt WE, Creutzfeldt W, Wuttke W. Contrasting effects of pituitary adenylate cyclase activating polypeptide (PACAP) on in vivo and in vitro prolactin and growth hormone release in male rats. Life Sci 1992; 51: 823-830.
40. Bleasdale JE, Thakur NR, Gremban RS et al. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther 1990; 255: 756-768.
41. Thompson AK, Mostafapour SP, Denlinger LC, Bleasdale JE, Fisher SK. The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. J Biol Chem 1991; 266: 23856-23862.
42. Smallridge RC, Kiang JG, Gist ID, Fein HG, Galloway RJ. U-73122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effects in GH3 rat pituitary cells. Endocrinology 1992; 131: 1883-1888.
43. Summers ST, Cronin MJ. Phorbol esters enhance basal and stimulated adenylate cyclase activity in a pituitary cell line. Biochem Biophys Res Commun 1986; 135: 276-281.
44. Guerineau N, Drouhault R, Corcuff JB, Vacher AM, Vilayleck N, Mollard P. Galanin evokes a cytosolic calcium bursting mode and hormone release in GH3/B6 pituitary cells. FEBS Lett 1990; 276: 111-114.
45. Luckhoff A, Clapham DE. Inositol 1,3,4,5-tetrakisphosphate activates an endothelial Ca2 +-permeable channel. Nature 1992; 335: 356-358.
46. Zachary I, Sinnett-Smith J, Rozengurt E. Stimulation of tyrosine kinase activity in anti-phosphotyrosine immune complexes of Swiss 3T3 cell lysates occurs rapidly after addition of bombesin, vasopressin, and endothelin to intact cells. J Biol Chem 1991; 266: 24126-24132.
47. Zachary I, Sinnett-Smith J, Rozengurt E. Bombesin, vasopressin and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. J Biol Chem 1992; 267: 19031-19034.
48. Krown KA, Wang TF, Walker AM. Autocrine interaction between prolactin and its receptor occurs intracellularly in the 235-1 mammotroph cell line. Endocrinology 1994; 134: 1546-1552.
49. Rodriguez R, Imai A, Gershengorn MC. Phosphatidylinositol depletion in GH3 rat pituitary cells inhibits sustained responses to thyrotropin-releasing hormone. Reversal with myo-inositol. Mol Endocrinol 1987; 1: 802-807.
50. Signorella AP, Hymer WC. An enzyme-linked immunosorbent assay for rat prolactin. Anal Biochem 1984; 136: 372-381.
51. Green JM, Reade JL, Ware CF. Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods 1984; 70: 257-268.